A comprehensive review and meta-analysis of risk factors for statin-induced myopathy

被引：0
|
作者：
Khoa A. Nguyen
Lang Li
Deshun Lu
Aida Yazdanparast
Lei Wang
Rolf P. Kreutz
Elizabeth C. Whipple
Titus K. Schleyer
机构：
[1] Richard L. Roudebush VA Medical Center,Center for Health Information and Communication, Department of Veterans Affairs (VA), Veterans Health Administration, Health Service Research and Development Service (CIN 13
[2] Purdue University,416)
[3] The Ohio State University,Department of Pharmacy Practice, College of Pharmacy
[4] Indiana University School of Medicine,Department of Biomedical Informatics, College of Medicine
[5] Indiana University School of Medicine,Division of Clinical Pharmacology, Department of Medicine
[6] Indiana University School of Medicine,Center for Computational Biology and Bioinformatics
[7] Indiana University School of Medicine,Department of Medicine, Krannert Institute of Cardiology
[8] Indiana University School of Medicine,Research and Translational Sciences
[9] Regenstrief Institute,Department of Medicine
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
Statins; Risks; Risk factors; Comprehensive review; Myotoxicity; Statin-induced myopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1099 / 1109
页数：10
相关论文
共 50 条
  • [1] A comprehensive review and meta-analysis of risk factors for statin-induced myopathy
    Nguyen, Khoa A.
    Li, Lang
    Lu, Deshun
    Yazdanparast, Aida
    Wang, Lei
    Kreutz, Rolf P.
    Whipple, Elizabeth C.
    Schleyer, Titus K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (09) : 1099 - 1109
  • [2] The association ofGATMpolymorphism with statin-induced myopathy: a systematic review and meta-analysis
    Liu, Mengyuan
    Fan, Fangfang
    Zhang, Yan
    Li, Jianping
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (03) : 349 - 357
  • [3] The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis
    Mengyuan Liu
    Fangfang Fan
    Yan Zhang
    Jianping Li
    European Journal of Clinical Pharmacology, 2021, 77 : 349 - 357
  • [4] Statin-induced myopathy: a review and update
    Abd, Thura T.
    Jacobson, Terry A.
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (03) : 373 - 387
  • [5] Statin-induced myopathy
    Gounden, Ronald
    Blockman, Marc
    CARDIOVASCULAR JOURNAL OF AFRICA, 2008, 19 (03) : 156 - 157
  • [6] Statin-induced Myopathy
    Kandzia, I.
    Kowar, M.
    Jacobs, A. H.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2018, 51 : 139 - 139
  • [7] Prevalence of Risk Factors for Statin-Induced Myopathy in Rheumatoid Arthritis Patients
    Toms, Tracey E.
    Smith, Jacqueline P.
    Panoulas, Vasileios F.
    Douglas, Karen M. J.
    Saratzis, Athanasios N.
    Kitas, George D.
    MUSCULOSKELETAL CARE, 2010, 8 (01) : 2 - 9
  • [8] On the mechanisms of statin-induced myopathy
    Laaksonen, Reijo
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (06) : 529 - 531
  • [9] STATIN-INDUCED NECROTIZING MYOPATHY
    Ademi, Besim
    Rothwell, William B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S598 - S598
  • [10] Statin-Induced Autoimmune Myopathy
    Nemati, Maryam
    Srai, Meena
    Rudrangi, Rajani
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
12345